Skip to main content
OpenTrials

Clinical trial condition

Atypical Fibroxanthoma

Explore clinical trials studying Atypical Fibroxanthoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Atypical Fibroxanthoma trial results

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions
Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 381 locations
View Trial Details

Related conditions